Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tivic Health Systems (TIVC) EBITDA (2021 - 2025)

Tivic Health Systems (TIVC) has 5 years of EBITDA data on record, last reported at -$2.5 million in Q3 2025.

  • For Q3 2025, EBITDA fell 73.52% year-over-year to -$2.5 million; the TTM value through Sep 2025 reached -$7.5 million, down 17.35%, while the annual FY2024 figure was -$5.7 million, 31.34% up from the prior year.
  • EBITDA reached -$2.5 million in Q3 2025 per TIVC's latest filing, down from -$1.9 million in the prior quarter.
  • Across five years, EBITDA topped out at -$1.1 million in Q2 2021 and bottomed at -$3.0 million in Q2 2022.
  • Average EBITDA over 5 years is -$1.9 million, with a median of -$1.9 million recorded in 2025.
  • Peak YoY movement for EBITDA: tumbled 186.07% in 2022, then surged 43.25% in 2024.
  • A 5-year view of EBITDA shows it stood at -$2.3 million in 2021, then grew by 1.57% to -$2.3 million in 2022, then grew by 0.53% to -$2.2 million in 2023, then surged by 31.24% to -$1.5 million in 2024, then crashed by 60.92% to -$2.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$2.5 million in Q3 2025, -$1.9 million in Q2 2025, and -$1.5 million in Q1 2025.